Andrew Jawa

Andrew Jawa

Auto-generated profile, based on publicly available information

Andrew Jawa

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
KMKuhan A. Mahendraraj
Kuhan A. Mahendraraj
JAJoseph Abboud
Joseph Abboud
AAApril Armstrong
April Armstrong
LALuke Austin
Luke Austin
TBTyler Brolin
Tyler Brolin
AJAndrew Jawa
Andrew Jawa

1 December 2020 in JSES International
Verified
Journal Article
Open access
SSSarav S. Shah
Sarav S. Shah
BGBenjamin T. Gaal
Benjamin T. Gaal
ARAlexander M. Roche
Alexander M. Roche
SNSurena Namdari
Surena Namdari
BGBrian M. Grawe
Brian M. Grawe
LGLawrence V. Gulotta
Lawrence V. Gulotta
Globally, reverse shoulder arthroplasty (RSA) has moved away from the Grammont design to modern prosthesis designs. The purpose of this 2-part study was to systematically review each of the most common complications of RSA, limiting each search to publications in 2010 or later. In this part (part I), we examined (1) scapular notching (SN), (2) periprosthetic infection (PJI), (3) mechanical failure (glenoid or humeral component), and (4) neurologic injury (NI). Four separate PubMed database searches were performed following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Overall, 113 studies on SN, 62 on PJI, 34 on mechanical failure, and 48 on NI were included in our reviews. Univariate analysis was performed with the χ2 or Fisher exact test. The Grammont design had a higher SN rate vs. all other designs combined (42.5% vs. 12.3%, P < .001). The onlay humeral design had a lower rate than the lateralized glenoid design (10.5% vs. 14.8%, P < .001). The PJI rate was 2.4% for primary RSA and 2.6% for revision RSA. The incidence of glenoid and humeral component loosening was 2.3% and 1.4%, respectively. The Grammont design had an increased NI rate vs. all other designs combined (0.9% vs. 0.1%, P = .04). Focused systematic reviews of the recent literature with a large volume of RSAs demonstrate that with the use of non-Grammont modern prosthesis designs, complications including SN, PJI, glenoid component loosening, and NI are significantly reduced compared with previous studies. As the indications for RSA continue to expand, it is imperative to accurately track the rates and types of complications to justify its cost and increased indications.

19 April 2022 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JKJacob M. Kirsch
Jacob M. Kirsch
RPRichard N. Puzzitiello
Richard N. Puzzitiello
DSDaniel Swanson
Daniel Swanson
KLKiet Le
Kiet Le
PHPaul-Anthony Hart
Paul-Anthony Hart
AJAndrew Jawa
Andrew Jawa
Background: Reverse shoulder arthroplasty (RSA) is increasingly being utilized for the treatment of primary osteoarthritis. However, limited data are available regarding the outcomes of RSA as compared with anatomic total shoulder arthroplasty (TSA) in the setting of osteoarthritis. Methods: We performed a retrospective matched-cohort study of patients who had undergone TSA and RSA for the treatment of primary osteoarthritis and who had a minimum of 2 years of follow-up. Patients were propensity score-matched by age, sex, body mass index (BMI), preoperative American Shoulder and Elbow Surgeons (ASES) score, preoperative active forward elevation, and Walch glenoid morphology. Baseline patient demographics and clinical outcomes, including active range of motion, ASES score, Single Assessment Numerical Evaluation (SANE), and visual analog scale (VAS) for pain, were collected. Clinical and radiographic complications were evaluated. Results: One hundred and thirty-four patients (67 patients per group) were included; the mean duration of follow-up (and standard deviation) was 30 ± 10.7 months. No significant differences were found between the TSA and RSA groups in terms of the baseline or final VAS pain score (p = 0.99 and p = 0.99, respectively), ASES scores (p = 0.99 and p = 0.49, respectively), or SANE scores (p = 0.22 and p = 0.73, respectively). TSA was associated with significantly better postoperative active forward elevation (149° ± 13° versus 142° ± 15°; p = 0.003), external rotation (63° ± 14° versus 57° ± 18°; p = 0.02), and internal rotation (≥L3) (68.7% versus 37.3%; p < 0.001); however, there were only significant baseline-to-postoperative improvements in internal rotation (gain of ≥4 levels in 53.7% versus 31.3%; p = 0.009). The overall complication rate was 4.5% (6 of 134), with no significant difference between TSA and RSA (p = 0.99). Radiolucent lines were observed in association with 14.9% of TSAs, with no gross glenoid loosening. One TSA (1.5%) was revised to RSA for the treatment of a rotator cuff tear. No loosening or revision was encountered in the RSA group. Conclusions: When performed for the treatment of osteoarthritis, TSA and RSA resulted in similar short-term patient-reported outcomes, with better postoperative range of motion after TSA. Longer follow-up is needed to determine the ultimate value of RSA in the setting of osteoarthritis. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

1 July 2016 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
RPRobert L. Parisien
Robert L. Parisien
PYPaul H. Yi
Paul H. Yi
LHLaura Hou
Laura Hou
XLXinning Li
Xinning Li
AJAndrew Jawa
Andrew Jawa

11 November 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MCMichael P. Carducci
Michael P. Carducci
GGGregory Gasbarro
Gregory Gasbarro
Mariano E. MenendezMariano E. Menendez
Mariano E. Menendez
KMKuhan A. Mahendraraj
Kuhan A. Mahendraraj
DMDavid A. Mattingly
David A. Mattingly
AJAndrew Jawa
Andrew Jawa
Background: Lower-extremity arthroplasty constitutes the largest burden on health-care spending of any Medicare diagnosis group. Demand for upper extremity arthroplasty also continues to rise. It is necessary to better understand costs as health care shifts toward a bundled-payment accounting approach. We aimed (1) to identify whether variation exists in total cost for different types of joint arthroplasty, and, if so, (2) to determine which cost parameters drive this variation. Methods: The cost of the episode of inpatient care for 22,215 total joint arthroplasties was calculated by implementing time-driven activity-based costing (TDABC) at a single orthopaedic specialty hospital from 2015 to 2018. Implant price, supply costs, personnel costs, and length of stay for total knee, total hip, anatomic total shoulder, reverse total shoulder, total elbow, and total ankle arthroplasty were analyzed. Individual cost parameters were compared with total cost and volume. Results: Higher implant cost appeared to correlate with higher total costs and represented 53.8% of the total cost for an inpatient care cycle. Total knee arthroplasty was the least-expensive and highest-volume procedure, whereas total elbow arthroplasty had the lowest volume and highest cost (1.65 times more than that of total knee arthroplasty). Length of stay was correlated with increased personnel cost but did not have a significant effect on total cost. Conclusions: Total inpatient cost at our orthopaedic specialty hospital varied by up to a factor of 1.65 between different fields of arthroplasty. The highest-volume procedures—total knee and hip arthroplasty—were the least expensive, driven predominantly by lower implant purchase prices. Clinical Relevance: We are not aware of any previous studies that have accurately compared cost structures across upper and lower-extremity arthroplasty with a uniform methodology. The present study, because of its uniform accounting process, provides reliable data that will allow clinicians to better understand cost relationships between different procedures.

1 July 2021 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
MMMichael A. Moverman
Michael A. Moverman
MMMariano E. Menendez
Mariano E. Menendez
KMKuhan A. Mahendraraj
Kuhan A. Mahendraraj
TPTeja Polisetty
Teja Polisetty
AJAndrew Jawa
Andrew Jawa
JLJonathan C. Levy
Jonathan C. Levy